Literature DB >> 21731815

Valsalva retinopathy in pregnancy. Should we treat?

Hany El-Defrawy1, Ahmed Sallam, Cordelia J McKechnie, Hadi Zambarakji.   

Abstract

Entities:  

Year:  2011        PMID: 21731815      PMCID: PMC3127496          DOI: 10.1258/shorts.2011.011035

Source DB:  PubMed          Journal:  JRSM Short Rep        ISSN: 2042-5333


× No keyword cloud information.
We report two cases of Valsalva retinopathy that have developed during the last trimester of pregnancy with spontaneous resolution and improvement of visual acuity.

Case 1

A 26-year-old Caucasian woman at 37 weeks gestation presented to the eye casualty with a sudden history of reduced vision and floaters in the left eye following an episode of sneezing. Her visual acuity was 6/6 and 6/60 in her right and left eyes, respectively. Anterior segment examination was unremarkable. Pupil reactions were normal. Fundus examination of the right eye was normal. Fundus examination of the left eye showed a premacular and vitreous haemorrhage (Figure 1). The patient was reviewed 2 weeks after she had a normal vaginal delivery and her vision had spontaneously improved to 6/6 in the left eye with near-total resolution of the retinal and vitreous haemorrhage.
Figure 1

Color fundus photograph of the left eye showing a preretinal and subhyaloid haemorrhage

Color fundus photograph of the left eye showing a preretinal and subhyaloid haemorrhage

Case 2

A 34-year-old Afro-Caribbean woman at 37 weeks gestation presented to eye casualty because of sudden blurring of vision in the left eye following an episode of vomiting. Her visual acuity was 6/6 and counting fingers in the right and left eyes, respectively. Anterior segment examination was unremarkable. Fundus examination of the right eye was normal and in the left showed a premacular (subhyaloid) haemorrhage (Figure 2). Her blood pressure, full blood count, coagulation profile, fasting blood sugar, sickle cell tests were all normal. The patient was managed conservatively. The patient had an elective Caesarian section at 38 weeks. At 5-month follow-up, her corrected visual acuity improved to 6/6 with complete resolution of the subhyaloid haemorrhage.
Figure 2

Color fundus photograph of the left eye showing a dense premacular subhyaloid haemorrhage

Color fundus photograph of the left eye showing a dense premacular subhyaloid haemorrhage

Discussion

Valsalva retinopathy is a unilateral or bilateral condition that occurs when increased intra-thoracic or intra-abdominal pressure transmitted to the eye causes a sharp rise in the intraocular venous pressure and rupture of superficial retinal capillaries. Patients usually give a history of sudden visual loss following a bout of heaving lifting, straining, coughing or vomiting.[1] Pregnancy is known to exert several hormonal, immunological and hematologic changes that increase the risk of haemorrhage and valsalva retinopathy. Moreover, the enlarging uterus causes elevation of intra-abdominal pressure and compresses the veins leading to increase in the intravenous pressure which increases the risk further.[2] Valsalva maneuvers typically result in superficial retinal haemorrhages (sub-internal limiting membrane; subhyaloid) with a predilection for the macula, but subretinal, retinal and vitreous haemorrhages have been reported. The prognosis is variable; however complete visual recovery over several months is possible. Some patients may develop a poor visual outcome due to the presumed toxic effects of a dense premacular haemorrhage on the retinal pigment epithelium and/or epiretinal membrane formation. Appropriate investigations to rule out known causes of retinal and vitreal haemorhages should be done.[2] Different techniques have been employed to treat premacular haemorrhage. Several case series have demonstrated the feasibility of Nd-YAG laser to puncture the posterior aspect of the vitreous thereby allowing drainage of premacular haemorrhage into the vitreous cavity. This may allow rapid restoration of vision and reduce the risk of visual loss associated with longstanding premacular haemorrhages,[3,4] however there is a risk of photomechanical retinal injury. Others have suggested early YAG laser treatment to achieve maximum benefit and allow complete drainage of the haemorrhage.[5] Vitrectomy surgery has also been used with success.[6] We present two cases in whom a conservative approach was adopted with a good outcome. The current literature lacks useful data to address the safety to YAG laser or surgical interventions to the fetus and the ideal timing for any proposed intervention. There is also no general agreement on the optimum obstetric and anaesthetic management of such cases. Our first patient had a normal vaginal delivery while the second patient delivered by Caesarean section, however there is no evidence that Caesarean section is necessary or that a spontaneous vaginal delivery may increase the risk of recurrent haemorrhage. Furthermore, general anaesthesia may cause a re-bleed due to vasodilation induced by hypoxia and hypercarpea, thereby increasing the retinal venous pressure.[7] Extubation may lead to significant rises in venous pressure secondary to coughing. Epidural anaesthesia has been also associated with retinal haemorrhage due to an increase in the cerebrospinal fluid pressure within the epidural space which may lead to elevated retinal venous pressure and subsequent haemorrhage.[7] In summary, we report two patients with Valsalva retinopathy during pregnancy managed conservatively with a good outcome. Close discussion between the treating ophthalmologist and obstetrician is necessary to discuss the treatment options and the possible risks with each method of delivery and anaesthesia.

DECLARATIONS

Competing interests

None declared

Funding

None

Ethical approval

Written consent to publication has been obtained from the patients

Guarantor

HZ

Contributorship

HED conceived and designed the idea, acquired the data and drafted the manuscript; AS drafted and critically revised the manuscript; CJM critically revised the manuscript; HJZ critically revised the manuscript and supervised the study

Acknowledgements

None

Reviewer

Deb Sahu
  7 in total

1.  Valsalva maculopathy.

Authors:  Anthony Chapman-Davies; Anka Lazarevic
Journal:  Clin Exp Optom       Date:  2002-01       Impact factor: 2.742

2.  Post-chemotherapy premacular subhyaloid haemorrhage.

Authors:  C M G Cheung; M T Benson
Journal:  Eye (Lond)       Date:  2003-01       Impact factor: 3.775

3.  Caesarean section following a recent retinal haemorrhage.

Authors:  K E Chidley; R Law; R G Vanner
Journal:  Anaesthesia       Date:  1998-05       Impact factor: 6.955

4.  Intravitreal tPA and SF6 promote clearing of premacular subhyaloid hemorrhages in shaken and battered baby syndrome.

Authors:  M D Conway; G A Peyman; M Recasens
Journal:  Ophthalmic Surg Lasers       Date:  1999-06

5.  Nd:YAG laser treatment for premacular subhyaloid haemorrhage.

Authors:  C A Rennie; D K Newman; M P Snead; D W Flanagan
Journal:  Eye (Lond)       Date:  2001-08       Impact factor: 3.775

6.  Long-term results after drainage of premacular subhyaloid hemorrhage into the vitreous with a pulsed Nd:YAG laser.

Authors:  M W Ulbig; G Mangouritsas; H H Rothbacher; A M Hamilton; J D McHugh
Journal:  Arch Ophthalmol       Date:  1998-11

7.  Valsalva retinopathy in pregnancy: a case report.

Authors:  Abdullah S Al-Mujaini; Carolina C Montana
Journal:  J Med Case Rep       Date:  2008-04-07
  7 in total
  3 in total

Review 1.  Valsalva Retinopathy in Twin-Pregnancy: A Case Report and Literature Review.

Authors:  Naiyang Li; Zhe Zhu; Genrong Yi; Sheng Li; Xiaotong Han
Journal:  Am J Case Rep       Date:  2018-01-02

2.  Posterior Hyaloidotomy by Nd:YAG Laser Application in a Patient with Postpartum Depression Caused by Valsalva Retinopathy.

Authors:  Mutlu Cihan Dağlioğlu; Mesut Coşkun; Nilüfer Ilhan; Esra Ayhan Tuzcu; Mustafa Ari; Emre Ayintap; Ozgür Ilhan
Journal:  Case Rep Ophthalmol       Date:  2013-04-05

3.  Demographic profile, clinical features, and outcome of peripapillary subretinal hemorrhage: an observational study.

Authors:  Ming Zou; Yi Zhang; Xi Huang; Sheng Gao; Junjun Zhang
Journal:  BMC Ophthalmol       Date:  2020-04-19       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.